Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10571)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 14, 2020 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang Q, Lou Y, Bai XL, Liang TB. Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies. World J Gastroenterol 2020; 26(26): 3720-3736 [PMID: 32774053 DOI: 10.3748/wjg.v26.i26.3720] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i26/3720.htm |
| Number | Citing Articles |
| 1 |
Giulia Milardi, Ana Lleo. Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer Treatment. Cancers 2023; 15(7): 2182 doi: 10.3390/cancers15072182
|
| 2 |
Elizabeth R. M. Zunica, Elizabeth C. Heintz, Christopher L. Axelrod, John P. Kirwan. Obesity Management in the Primary Prevention of Hepatocellular Carcinoma. Cancers 2022; 14(16): 4051 doi: 10.3390/cancers14164051
|
| 3 |
Kyoungdo Mun, Jiwon Han, Pureun Roh, Jonggeun Park, Gahee Kim, Wonhee Hur, Jeongwon Jang, Jongyoung Choi, Seungkew Yoon, Youngkyoung You, Hojoong Choi, Pilsoo Sung. Isolation and characterization of cancer-associated fibroblasts in the tumor microenvironment of hepatocellular carcinoma. Journal of Liver Cancer 2023; 23(2): 341 doi: 10.17998/jlc.2023.04.30
|
| 4 |
Tao Liu, Ya Guo, Yanxia Liao, Jinping Liu. Mechanism-guided fine-tuned microbiome potentiates anti-tumor immunity in HCC. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1333864
|
| 5 |
N. Ivanenko. BIOFILM AND TUMOR: INTERPRETATION OF INTERACTION AND TREATMENT STRATEGIES. Review. Medical Science of Ukraine (MSU) 2021; 17(1): 104 doi: 10.32345/2664-4738.1.2021.13
|
| 6 |
Valli De Re, Anna Rossetto, Alessandro Rosignoli, Elena Muraro, Vito Racanelli, Maria Lina Tornesello, Aron Zompicchiatti, Alessandro Uzzau. Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.897703
|
| 7 |
Shirley Lewis, Laura Dawson, Aisling Barry, Teodor Stanescu, Issa Mohamad, Ali Hosni. Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity. JHEP Reports 2022; 4(8): 100498 doi: 10.1016/j.jhepr.2022.100498
|
| 8 |
Mengchao Wei, Manxia Lin, Xian Zhong, Zihao Dai, Shunli Shen, Shaoqiang Li, Zhenwei Peng, Ming Kuang. Role of Preoperational Imaging Traits for Guiding Treatment in Single ≤ 5 cm Hepatocellular Carcinoma. Annals of Surgical Oncology 2022; 29(8): 5144 doi: 10.1245/s10434-022-11344-3
|
| 9 |
Tanner Wright, Yalong Wang, Sabrina A. Stratton, Manu Sebastian, Bin Liu, David G. Johnson, Mark T. Bedford. Loss of the methylarginine reader function of SND1 confers resistance to hepatocellular carcinoma. Biochemical Journal 2023; 480(22): 1805 doi: 10.1042/BCJ20230384
|
| 10 |
Yuri S. Velichko, Nicolo Gennaro, Meghana Karri, Matthew Antalek, Ulas Bagci. A Comprehensive Review of Deep Learning Approaches for Magnetic Resonance Imaging Liver Tumor Analysis. Advances in Clinical Radiology 2023; 5(1): 1 doi: 10.1016/j.yacr.2023.06.001
|
| 11 |
Hugo Pinto-Marques, Joana Cardoso, Sílvia Silva, João L. Neto, Maria Gonçalves-Reis, Daniela Proença, Marta Mesquita, André Manso, Sara Carapeta, Mafalda Sobral, Antonio Figueiredo, Clara Rodrigues, Adelaide Milheiro, Ana Carvalho, Rui Perdigoto, Eduardo Barroso, José B. Pereira-Leal. A Gene Expression Signature to Select Hepatocellular Carcinoma Patients for Liver Transplantation. Annals of Surgery 2022; 276(5): 868 doi: 10.1097/SLA.0000000000005637
|
| 12 |
Jérôme Ghidaglia, Nicolas Golse, Alina Pascale, Mylène Sebagh, Florent L. Besson. 18F-FDG /18F-Choline Dual-Tracer PET Behavior and Tumor Differentiation in HepatoCellular Carcinoma. A Systematic Review. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.924824
|
| 13 |
Shubhraneel Saha, Nikita Pradhan, Neha B, Ravikiran Mahadevappa, Shilpi Minocha, Saran Kumar. Cancer plasticity: Investigating the causes for this agility. Seminars in Cancer Biology 2023; 88: 138 doi: 10.1016/j.semcancer.2022.12.005
|
| 14 |
Kamil Wawrowicz, Agnieszka Majkowska-Pilip, Marzena Szwed, Kinga Żelechowska-Matysiak, Ewelina Chajduk, Aleksander Bilewicz. Oxidative Status as an Attribute for Selective Antitumor Activity of Platinum-Containing Nanoparticles against Hepatocellular Carcinoma. International Journal of Molecular Sciences 2022; 23(23): 14773 doi: 10.3390/ijms232314773
|
| 15 |
Mohammad Mirza-Aghazadeh-Attari, Bharath Ambale Venkatesh, Mounes Aliyari Ghasabeh, Alireza Mohseni, Seyedeh Panid Madani, Ali Borhani, Haneyeh Shahbazian, Golnoosh Ansari, Ihab R. Kamel. The Additive Value of Radiomics Features Extracted from Baseline MR Images to the Barcelona Clinic Liver Cancer (BCLC) Staging System in Predicting Transplant-Free Survival in Patients with Hepatocellular Carcinoma: A Single-Center Retrospective Analysis. Diagnostics 2023; 13(3): 552 doi: 10.3390/diagnostics13030552
|
| 16 |
Sheng Wang, Songsen Gao, Liang Shan, Xueyi Qian, Jiajie Luan, Xiongwen Lv. Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma. PeerJ 2023; 11: e14691 doi: 10.7717/peerj.14691
|
| 17 |
Dirk Andreas Ridder, Arndt Weinmann, Mario Schindeldecker, Lana Louisa Urbansky, Kristina Berndt, Tiemo Sven Gerber, Hauke Lang, Johannes Lotz, Karl J. Lackner, Wilfried Roth, Beate Katharina Straub. Comprehensive clinicopathologic study of alpha fetoprotein‐expression in a large cohort of patients with hepatocellular carcinoma. International Journal of Cancer 2022; 150(6): 1053 doi: 10.1002/ijc.33898
|
| 18 |
Woo Sun Rou, Hyuk Soo Eun, Sorim Choung, Hong Jae Jeon, Jong Seok Joo, Sun Hyung Kang, Eaum Seok Lee, Seok Hyun Kim, In Sun Kwon, Bon Jeong Ku, Byung Seok Lee. Prognostic Value of Erythroblastic Leukemia Viral Oncogene Homolog 2 and Neuregulin 4 in Hepatocellular Carcinoma. Cancers 2023; 15(9): 2634 doi: 10.3390/cancers15092634
|
| 19 |
Alexandra D. Ladd, Sergio Duarte, Ilyas Sahin, Ali Zarrinpar. Mechanisms of drug resistance in HCC. Hepatology 2024; 79(4): 926 doi: 10.1097/HEP.0000000000000237
|
| 20 |
Jie Bao, Yan Yu. Identification of a prognostic evaluator from glutamine metabolic heterogeneity studies within and between tissues in hepatocellular carcinoma. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1241677
|
| 21 |
Mudassier Ahmad, Anupam Dhasmana, Prateek Suresh Harne, Asif Zamir, Bilal Bin Hafeez. Chemokine clouding and liver cancer heterogeneity: Does it impact clinical outcomes?. Seminars in Cancer Biology 2022; 86: 1175 doi: 10.1016/j.semcancer.2022.02.015
|
| 22 |
Christel F. A. Ramirez, Daniel Taranto, Masami Ando-Kuri, Marnix H. P. de Groot, Efi Tsouri, Zhijie Huang, Daniel de Groot, Roelof J. C. Kluin, Daan J. Kloosterman, Joanne Verheij, Jing Xu, Serena Vegna, Leila Akkari. Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-46835-2
|
| 23 |
Valentina Leone, Adnan Ali, Achim Weber, Darjus Felix Tschaharganeh, Mathias Heikenwalder. Liver Inflammation and Hepatobiliary Cancers. Trends in Cancer 2021; 7(7): 606 doi: 10.1016/j.trecan.2021.01.012
|
| 24 |
Rengul Cetin-Atalay, Deniz Cansen Kahraman, Esra Nalbat, Ahmet Sureyya Rifaioglu, Ahmet Atakan, Ataberk Donmez, Heval Atas, M. Volkan Atalay, Aybar C. Acar, Tunca Doğan. Data Centric Molecular Analysis and Evaluation of Hepatocellular Carcinoma Therapeutics Using Machine Intelligence-Based Tools. Journal of Gastrointestinal Cancer 2021; 52(4): 1266 doi: 10.1007/s12029-021-00768-x
|
| 25 |
Jaime Sánchez-Meza, Marina Campos-Valdez, José Alfredo Domínguez-Rosales, Juliana Marisol Godínez-Rubí, Sarai Citlalic Rodríguez-Reyes, Erika Martínez-López, Guillermo M. Zúñiga-González, Laura Verónica Sánchez-Orozco. Chronic Administration of Diethylnitrosamine and 2-Acetylaminofluorene Induces Hepatocellular Carcinoma in Wistar Rats. International Journal of Molecular Sciences 2023; 24(9): 8387 doi: 10.3390/ijms24098387
|
| 26 |
Samer Tohme, Hamza O Yazdani, Amaan Rahman, Sanah Handu, Sidrah Khan, Tanner Wilson, David A Geller, Richard L Simmons, Michele Molinari, Christof Kaltenmeier, José L. Mauriz. The Use of Machine Learning to Create a Risk Score to Predict Survival in Patients with Hepatocellular Carcinoma: A TCGA Cohort Analysis. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/5212953
|
| 27 |
Begum Dariya, Sujatha Peela, Ganji Purnachandra Nagaraju. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 1 doi: 10.1016/B978-0-323-98806-3.00001-5
|
| 28 |
Chen Yang, Senquan Zhang, Zhuoan Cheng, Zhicheng Liu, Linmeng Zhang, Kai Jiang, Haigang Geng, Ruolan Qian, Jun Wang, Xiaowen Huang, Mo Chen, Zhe Li, Wenxin Qin, Qiang Xia, Xiaonan Kang, Cun Wang, Hualian Hang. Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer. Genome Medicine 2022; 14(1) doi: 10.1186/s13073-022-01143-6
|
| 29 |
Nwamaka Iloani, Areeba Hafeez, Serena Bao, Victoria Dulemba, Christoffer Lambring, Umesh T. Sankpal, Riyaz Basha. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 185 doi: 10.1016/B978-0-323-98807-0.00013-2
|
| 30 |
Batoul Abi Zamer, Bilal Rah, Manju Nidagodu Jayakumar, Wafaa Abumustafa, Mawieh Hamad, Jibran Sualeh Muhammad. DNA methylation-mediated epigenetic regulation of oncogenic RPS2 as a novel therapeutic target and biomarker in hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2024; 696: 149453 doi: 10.1016/j.bbrc.2023.149453
|